Lacdigest
Roche opens new Swiss Institute of Human Biology research facility
The new building is part of a 1.5bn euro site investment
Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions
New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...
Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education
UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...
Recognizing C diff Awareness Month in 2024
Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every...
Honoring Educational Partners at ACG
The recent ACG conference was an opportunity for members of the Medscape team to shine a light on their educational partners and honor them for their exceptional work.On October 21,...
Medscape Collaborates for Health Equity at DDW 2023
Recently, DDW 2023 took place in Chicago, IL, and Medscape was on-site with patient advocacy organizations to help educate clinicians on health equity in gastroenterology.Medscape was joined during the conference...
AbbVie’s Rinvoq granted NICE recommendation as ulcerative colitis treatment
The recommendation is for adults living with the condition in England and Wales
Merck’s Keytruda meets primary endpoint in phase 3 gastric cancer trial
Gastric cancer is the fourth leading cause of cancer death worldwide
Italy accelerates the path towards digital therapeutics implementation
PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy
New data for Recordati’s Isturisa reinforces benefit in Cushing’s disease
Drug provided 'rapid and sustained' normalisation of mean urinary-free cortisol levels
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country
FDA approves Recordati’s Cushing disease drug Isturisa
Important new treatment option for patients with rare disorder